Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Thera (NQ: VKTX )

53.01 +2.24 (+4.41%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 16,150,675
Open 51.30
Bid (Size) 53.20 (3)
Ask (Size) 53.38 (1)
Prev. Close 50.77
Today's Range 51.05 - 54.80
52wk Range 8.280 - 99.41
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The 3 Smartest Biotech Stocks to Buy With $5K Right Now
With global obesity numbers bursting at the seams, some of the smartest biotech stocks to buy are those with weight loss drugs. 
Via InvestorPlace
The Top 3 Weight Loss Drug Stocks to Buy for Huge Gains
Consider buying shares in these pharma companies, each of which is a leader in the weight loss drug sector. 
Via InvestorPlace

Performance

YTD
+189.99%
+189.99%
1 Month
-16.93%
-16.93%
3 Month
-33.32%
-33.32%
6 Month
+184.85%
+184.85%
1 Year
+239.37%
+239.37%

More News

Read More
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
Via The Motley Fool
Better Growth Stock: Archer Aviation or Viking Therapeutics?
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Viking Therapeutics Unusual Options Activity For June 25
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $600 Today
Via Benzinga
Viking Therapeutics Unusual Options Activity For June 12
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The Best Biotech Stock to Invest $1,000 in Right Now
Via The Motley Fool
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street
Via The Motley Fool
2 Growth Stocks Wall Street Analysts Think Can Soar by at Least 80%
Via The Motley Fool
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It
Via The Motley Fool
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug
Via The Motley Fool
3 Stocks Under $10 Set to Quadruple by 2025: June Edition
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Stocks to Buy if You Want to Turn Your $1,000 into $10,000 Within 2 Years
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Stocks Quietly Preparing for a 10X Surge: June Edition
Via InvestorPlace
Skye Bioscience Pivots To Obesity After Glaucoma Flop; Shares Plummet
Via Investor's Business Daily
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
Via The Motley Fool
This High-Flying Stock Just Announced More Good News: Time to Buy?
Via The Motley Fool
Profiting from the Crowd: 3 Stocks Set to Surge on Retail Investor Enthusiasm
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Stock Market Revs To Highs On Nvidia, CrowdStrike, Yields: Weekly Review
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
The 3 Most Undervalued Pharma Stocks to Buy in June 2024
Via InvestorPlace
Topics Economy
Exposures Economy
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.